To include your compound in the COVID-19 Resource Center, submit it here.

BioSante adds $48 million in follow-on

BioSante Pharmaceuticals Inc. (NASDAQ:BPAX) raised $48 million through

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE